Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Nature Communications
|
March 19, 2025
Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals
George W Sledge, Takayuki Yoshino, Joanne Xiu, et al.
Communications Medicine
|
August 1, 2025
Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer
Yating Cheng, Norsang Lama, Ming Chen, et al.
Translational Oncology
|
January 19, 2021
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type
Jim Abraham, Amy B Heimberger, John Marshall, et al.
Cell Chemical Biology
|
April 2, 2019
Translocation of a Cell Surface Spliceosomal Complex Induces Alternative Splicing Events and Lymphoma Cell Necrosis
Sonal S Tonapi, Vaishali Pannu, Janet E Duncan, et al.
JAMA Network Open
|
March 18, 2026
An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins
Mark G Evans, Jennifer R Ribeiro, Todd Maney, et al.
NPJ Precision Oncology
|
June 15, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence
Sebastian Cole, Paul Campitelli, Brian Grieb, et al.
Cancer Research Communications
|
July 31, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
Hassan Ghani, Anthony Helmstetter, Jennifer R Ribeiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2020
Clinical Validation of a Machine-learning-derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer
Jim P Abraham, Daniel Magee, Chiara Cremolini, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Nature Communications
|
March 19, 2025
Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals
George W Sledge, Takayuki Yoshino, Joanne Xiu, et al.
Communications Medicine
|
August 1, 2025
Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer
Yating Cheng, Norsang Lama, Ming Chen, et al.
Translational Oncology
|
January 19, 2021
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type
Jim Abraham, Amy B Heimberger, John Marshall, et al.
Cell Chemical Biology
|
April 2, 2019
Translocation of a Cell Surface Spliceosomal Complex Induces Alternative Splicing Events and Lymphoma Cell Necrosis
Sonal S Tonapi, Vaishali Pannu, Janet E Duncan, et al.
JAMA Network Open
|
March 18, 2026
An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins
Mark G Evans, Jennifer R Ribeiro, Todd Maney, et al.
NPJ Precision Oncology
|
June 15, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence
Sebastian Cole, Paul Campitelli, Brian Grieb, et al.
Cancer Research Communications
|
July 31, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
Hassan Ghani, Anthony Helmstetter, Jennifer R Ribeiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2020
Clinical Validation of a Machine-learning-derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer
Jim P Abraham, Daniel Magee, Chiara Cremolini, et al.
Page
of 1